KIMBERLY MATZEL: Open Payments
NPI 1902909872 · BLUEFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 58 payments from 13 companies in 2025. Trend: 2023 $1,164 · 2024 $1,416 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $299 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $190 |
| Novo Nordisk Inc | 9 | $166 |
| AstraZeneca Pharmaceuticals LP | 6 | $120 |
| Exact Sciences Corporation | 4 | $76 |
| Astellas Pharma US Inc | 1 | $23 |
| PFIZER INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: JARDIANCE, REPATHA, OTEZLA, Ozempic, Cologuard Collection Kit, AIRSUPRA, Rybelsus, Veozah.
Industry payments across VA — which companies pay providers there.
